Csenge Advisory Group increased its stake in shares of Plains GP Holdings, L.P. (NYSE:PAGP – Free Report) by 6.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 22,757 shares of the pipeline company’s stock after purchasing an additional 1,415 shares during the quarter. Csenge Advisory Group’s holdings in Plains GP were worth $418,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Golden State Wealth Management LLC bought a new position in Plains GP during the fourth quarter valued at $33,000. Allworth Financial LP bought a new position in Plains GP during the 4th quarter valued at about $44,000. Hara Capital LLC purchased a new stake in Plains GP in the 3rd quarter worth about $57,000. Eastern Bank bought a new stake in Plains GP in the third quarter worth about $76,000. Finally, Continuum Advisory LLC boosted its position in shares of Plains GP by 10.0% during the third quarter. Continuum Advisory LLC now owns 6,990 shares of the pipeline company’s stock valued at $127,000 after buying an additional 637 shares during the period. Hedge funds and other institutional investors own 88.30% of the company’s stock.
Plains GP Trading Up 2.3 %
NYSE:PAGP opened at $21.58 on Wednesday. The firm has a 50-day simple moving average of $20.06 and a 200-day simple moving average of $19.15. Plains GP Holdings, L.P. has a one year low of $16.77 and a one year high of $22.31. The firm has a market cap of $4.26 billion, a P/E ratio of 25.39 and a beta of 1.58. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.92 and a current ratio of 1.01.
Plains GP Increases Dividend
Wall Street Analyst Weigh In
PAGP has been the topic of several recent analyst reports. Raymond James increased their price target on Plains GP from $23.00 to $24.00 and gave the stock a “strong-buy” rating in a report on Tuesday, January 28th. Morgan Stanley lowered Plains GP from an “overweight” rating to an “equal weight” rating and reduced their target price for the stock from $22.00 to $19.00 in a research note on Friday, October 25th. Wolfe Research raised shares of Plains GP from a “peer perform” rating to an “outperform” rating and set a $22.00 target price for the company in a research note on Friday, January 10th. Barclays upped their price target on shares of Plains GP from $18.00 to $19.00 and gave the stock an “underweight” rating in a report on Thursday, January 16th. Finally, StockNews.com lowered shares of Plains GP from a “buy” rating to a “hold” rating in a report on Monday, February 10th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Plains GP presently has a consensus rating of “Hold” and a consensus price target of $20.60.
Get Our Latest Stock Report on Plains GP
About Plains GP
Plains GP Holdings, L.P., through its subsidiary, Plains All American Pipeline, L.P., owns and operates midstream infrastructure systems in the United States and Canada. It operates in two segments, Crude Oil and Natural Gas Liquids (NGLs). The company engages in the gathering and transporting crude oil and NGLs using pipelines, gathering systems, and trucks.
Recommended Stories
- Five stocks we like better than Plains GP
- What is a SEC Filing?
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- What Are Dividends? Buy the Best Dividend Stocks
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- What Are Dividend Achievers? An Introduction
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Want to see what other hedge funds are holding PAGP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plains GP Holdings, L.P. (NYSE:PAGP – Free Report).
Receive News & Ratings for Plains GP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plains GP and related companies with MarketBeat.com's FREE daily email newsletter.